Research Triangle Park, NC (PRWEB) January 24, 2008
American Research Institute, Inc. (ARI) wrapped up the production of a series of PowerMeetings™ for GlaxoSmithKline in 2007. The meetings were held nationwide with key sales and management executives. ARI provided consulting and design services as well as all logistics, venue support, content development, and audio/video production for these events.
In advance of the meetings the ARI PowerMeeting™ team put in a great deal of preparation and rehearsal with the GSK presenters to make each meeting flow smoothly. The goal was to ensure that everyone was actively involved throughout the events and that their participation translated into learning. Each member of the audience was given a wireless response unit so they could provide immediate feedback to questions and scenarios posed throughout the event. This format created a highly engaging, interactive, and competitive environment for the attendees and presenters.
Barry Echols, Director of GSK Pharma Compliance said, "Compliance training is typically dry and tedious but the PowerMeetings format has taken this essential training to the next level and has even been called fun! ARI really has something here and we are very pleased with the results." Mr. Echols added: "ARI produced 12 PowerMeetings™ across the United States for GSK. In the process they helped us train over 90% of our management team, with close to 100% favorable feedback."
As one attendee commented, "I never realized Compliance Training could be this much fun!"
About American Research Institute
American Research Institute, Inc. ("ARI") is a leading provider of education and training services, allowing customers to achieve their maximum effectiveness through high-quality, educationally sound, and mission-critical training. ARI offers a wide range of services, from designing custom training solutions to full outsourcing of training divisions. ARI has a team of corporate education and training professionals providing superior training to both government agencies and commercial accounts.
# # #